ArticleLiver international : official journal of the International Association for the Study of the Liver2026

Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.

Ryu Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.